Document
IPR2017-01429, No. 5 Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Jun. 2, 2017)
Cite Document
IPR2017-01429, No. 5 Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Jun. 2, 2017)
+ More Snippets
Document
IPR2017-01429, No. 9 Preliminary Response Waiver - Waiver of Patent Owners Preliminary Response (P.T.A.B. Aug. 17, 2017)
Cite Document
IPR2017-01429, No. 9 Preliminary Response Waiver - Waiver of Patent Owners Preliminary Response (P.T.A.B. Aug. 17, 2017)
+ More Snippets
Document
IPR2017-01429, No. 4 Power of Attorney - Patent Owners Power of Attorney (P.T.A.B. Jun. 2, 2017)
Cite Document
IPR2017-01429, No. 4 Power of Attorney - Patent Owners Power of Attorney (P.T.A.B. Jun. 2, 2017)
+ More Snippets
Document
IPR2017-01429, No. 2 Petition - Petition for IPR 7,214,506 (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01429, No. 2 Petition - Petition for IPR 7,214,506 (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
IPR2017-01429, No. 3 Motion - Motion for Joinder (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01429, No. 3 Motion - Motion for Joinder (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
IPR2017-01429, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01429, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
JUBLIA, 203567, Label (Orange Book Sep. 22, 2016)
Cite Document
JUBLIA, 203567, Label (Orange Book Sep. 22, 2016)
+ More Snippets
Document
JUBLIA, 203567, Letter (Orange Book Sep. 22, 2016)
Cite Document
JUBLIA, 203567, Letter (Orange Book Sep. 22, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1596-245 Exhibit - A Healthy Ad Market (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1596-245 Exhibit - A Healthy Ad Market (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2055-102 Exhibit - Kaken Exhibit 2055 (P.T.A.B. Aug. 1, 2017)
Cite Document
IPR2017-00190, No. 2055-102 Exhibit - Kaken Exhibit 2055 (P.T.A.B. Aug. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 3003-350 Exhibit - Ex 3003 (P.T.A.B. Aug. 4, 2020)
Cite Document
IPR2017-00190, No. 3003-350 Exhibit - Ex 3003 (P.T.A.B. Aug. 4, 2020)
+ More Snippets
Document
IPR2017-00190, No. 1651-300 Exhibit - Consolidated Financial Results for Fiscal 2016 Reference Data of Financial Statements for the 3Q of Fiscal 2016 (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1651-300 Exhibit - Consolidated Financial Results for Fiscal 2016 Reference Data of Financial Statements for the 3Q of Fiscal 2016 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1556-205 Exhibit - Valeant Announces CEO Succession Plan And Changes To Board Of Directors Provides Accounting And Financial Reporting Update (P.T.A.B. Nov. 1, 20...
Cite Document
IPR2017-00190, No. 1556-205 Exhibit - Valeant Announces CEO Succession Plan And Changes To Board Of Directors Provides Accounting And Financial Reporting Update (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1535-330 Exhibit - Exhibit 1535a Pharmacy Benefit Management Are Reporting Requirements Pro or Anticompetitive¿¿¿ PM Danzon, International Journal of the Economics...
Cite Document
IPR2017-00190, No. 1535-330 Exhibit - Exhibit 1535a Pharmacy Benefit Management Are Reporting Requirements Pro or Anticompetitive¿¿¿ PM Danzon, International Journal of the Economics of Business, 2
+ More Snippets
Document
IPR2017-00190, No. 1643-292 Exhibit - Top 200 Drugs for 2005 by Sales (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1643-292 Exhibit - Top 200 Drugs for 2005 by Sales (P.T.A.B. Nov. 1, 2017)
+ More Snippets